Literature DB >> 227180

Effects of L-tryptophan on sleep onset insomniacs.

C C Brown, N J Horrom, A M Wagman.   

Abstract

Eighteen female subjects with demonstrated laboratory sleep onset latency greater than 20 minutes for two nights participated in this double blind study of the effectiveness of l-tryptophan as a hypnotic. Standard sleep recordings were made on 10 nights over a 3 month period with lights out occurring 20 minutes after drug administration (placebo, 1 gm. l-tryptophan, 3 gms. l-tryptophan). Neither dose of l-tryptophan differed from placebo as to the amount of REM, SWS or wakefulness, but 3 gms. significantly reduced sleep onset latency on some of the nights. Those subjects with latencies longer than 40 mins. had the greatest reduction in latency with 3 gms. and also evidenced high levels of anxiety on the Taylor Manifest Anxiety Scale initially. Subjects with latency between 20 and 40 minutes appeared to receive the longest lasting hypnotic effect from the higher dose. Adaptation to the sleep lab took place across the entire 10 nights of the study. Therefore, valid comparisons between treatments in a sleep study extending over a number of nights should be made between temporally adjacent samples.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227180

Source DB:  PubMed          Journal:  Waking Sleeping        ISSN: 0340-0905


  6 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Evaluation of L-tryptophan for treatment of insomnia: a review.

Authors:  D Schneider-Helmert; C L Spinweber
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  L-tryptophan administered to chronic sleep-onset insomniacs: late-appearing reduction of sleep latency.

Authors:  C L Spinweber
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 4.  Insomnia in Elderly Patients: Recommendations for Pharmacological Management.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Drugs Aging       Date:  2018-09       Impact factor: 3.923

5.  Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Authors:  G A Ricaurte; U D McCann
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

6.  Psychological and Sleep Effects of Tryptophan and Magnesium-Enriched Mediterranean Diet in Women with Fibromyalgia.

Authors:  Alejandro Martínez-Rodríguez; Jacobo Á Rubio-Arias; Domingo J Ramos-Campo; Cristina Reche-García; Belén Leyva-Vela; Yolanda Nadal-Nicolás
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.